IP Library › Granted Patent US 12,600,745
Granted Patent B2
US 12,600,745 · App. 18/281,943 · Granted Apr 14, 2026

Process for preparing B-[(7a, 1713)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid

Inventors: Roberto Lenna (S. Giorgio su Legnano, IT); Andrea Fasana (Nesso, IT)
Assignee: Industriale Chimica S.R.L.
C07J31/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,600,745
App. No.
18/281,943
Granted
Apr 14, 2026
Kind
B2
Abstract

The present invention relates to a process for preparing B-[(7α,17β)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid, also known as Fulvestrant-3-boronic acid or ZB716, whose structure is reported below.

Claims (9)

1 . A process for the synthesis of B-[(7α,17β)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid (ZB716), comprising the following steps:

a) reaction of intermediate N-3, (7α,17β)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol (Fulvestrant), with a triflating agent to obtain intermediate N-2, (7α,17β)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol-3-triflate:

b) reaction of intermediate N-2 with 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi-1,3,2-dioxaborolane to obtain intermediate N-1, (7α,17β)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-estra-1,3,5(10)-trien-17-ol:

c) treatment of intermediate N-1 to obtain compound ZB716, B-[(7α,17β)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid:

2 . The process according to claim 1 , wherein in step a) an aromatic bis(trifluoromethanesulfonimide) of general formula Ar—N(Tf) 2 is used as triflating agent, wherein Ar indicates the aromatic or heterocyclic radical and the N(Tf) 2 group is the radical:

3 . The process according to claim 2 , wherein said triflating agent is 1,1,1-trifluoro-N-phenyl-N-[(trifluoromethyl)sulfonyl]methanesulfonamide.

4 . The process according to claim 1 , wherein the reagent used in step c) for the conversion of intermediate N-1 into compound ZB716 is an alkali metal periodate.

5 . The process according to claim 4 , wherein said reagent is sodium periodate.

6 . Compound (7α,17β)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol-3-triflate:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2023
From: LENNA, ROBERTO; FASANA, ANDREA
To: INDUSTRIALE CHIMICA S.R.L.
Reel/Frame 064895/0568 →
Priority Claims (1)
IT 102021000008066 · Mar 31, 2021 · national
Continuity (1)
Related Publication 20240174711A1 · May 30, 2024
References Cited (6)
EP 3473630B1 · 2021 [cited by applicant]
WO 9500478 · 1995 [cited by applicant]
WO 2016004166A1 · 2016 [cited by applicant]
WO 2017192991A1 · 2017 [cited by applicant]
E. J. Brazier et al., “Fulvestrant: From the Laboratory to Commercial-Scale Manufacture,” Org. Process Res. Dev., 2010, vol. 14, No. 3, pp. 544-552. [cited by applicant]
J. Liu et al., “Fulvestrant-3 boronic acid (ZB716): an orally bioavailable selective estrogen receptor downregulator (SERD)”, J. Med. Chem., 2016, vol. 59, pp. 8134-8140. [cited by applicant]